Hostname: page-component-7b7567c8c-fvjsw Total loading time: 0 Render date: 2026-11-16T10:46:28.236Z Has data issue: false hasContentIssue false

Conflict of interest declaration

Published online by Cambridge University Press:  08 February 2008

Get access

Extract

David Ames has undertaken research with cholinesterase inhibitor drugs supported by Eisai, Janssen, Parke-Davis and Pfizer. He has received honoraria for talks and consultancies and some financial support to enable conference attendance from those four companies and from Novartis, the other pharmaceutical company to market a cholinesterase inhibitor in Australia.

Information

Type
For Debate
Copyright
Copyright © International Psychogeriatric Association 2007

Access options

Get access to the full version of this content by using one of the access options below. (Log in options will check for institutional or personal access. Content may require purchase if you do not have access.)

Article purchase

Temporarily unavailable